v3.25.2
Issuances of Common Shares and Warrants (Detail Narrative) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
May 15, 2025
Jan. 13, 2025
Jan. 07, 2025
Dec. 09, 2024
Oct. 16, 2024
Oct. 01, 2024
Apr. 28, 2025
Feb. 28, 2025
Nov. 27, 2024
May 31, 2025
May 31, 2024
Aug. 31, 2024
Agreed to cancelled, share purchase warrants                   3,311,687    
Description of incentives plan                   The Company established an Equity Incentive Plan whereby our Board, pursuant to shareholder approved amendments, may grant up to 1,745,259 stock options, restricted stock awards or restricted stock units to directors, officers, employees, and consultants with such number being increased to up to 10% of the issued share capital at the end of each calendar year, at the discretion of the board, pursuant to an evergreen formula    
Number of shares issued                   19,559,179   15,810,205
Proceeds from issuance of common stock                   $ 6,046,163 $ 4,208,731  
Stock based compensation expense                   $ 736,770 $ 395,726  
Stock Options                        
Number of shares granted                   586,500   696,500
Exercise price                   $ 1.41   $ 2.91
Exercise price repriced                   $ 3.46    
Non-vested stock options                   203,546    
Unrecognized non-cash stock-based compensation expense                   $ 498,642    
Weighted average remaining contractual life                   1 year 4 months 28 days    
Directors Officers And Employees [Member]                        
Number of shares granted 444,500                      
Exercise price $ 1.04                      
Weighted average remaining contractual life 5 years                      
Two employees [Member]                        
Number of shares granted           62,000            
Exercise price           $ 3.17            
Weighted average remaining contractual life           5 years            
two Scientific Advisor Board [Member]                        
Number of shares granted                 20,000      
Exercise price                 $ 2.10      
Weighted average remaining contractual life                 5 years      
Scientific Advisory Board And Consultant [Member]                        
Number of shares granted   50,000                    
Exercise price   $ 2.07                    
Weighted average remaining contractual life   5 years                    
Scientific Advisory Board [Member]                        
Number of shares granted       10,000                
Exercise price       $ 2.42                
Weighted average remaining contractual life       5 years                
On October 16, 2024 [Member]                        
Gross proceeds         $ 5,000,000.0              
Net proceeds         $ 4,500,000              
Agreed to cancelled, share purchase warrants         2,917,032              
Description of warrant issuance         We also issued the placement agent warrants to purchase up to 57,190, for a period of five years from the date of issuance shares at an exercise price of $3.825 per share              
Issued share purchase warrants         4,551,019              
Purchase common stock shares         4,551,019              
Common stock shares sold         1,633,987              
Common stock price per share         $ 3.06              
Purchase price         3.06              
Exercise price         $ 4.75              
Securities Purchase Agreement [Member] | On April 28, 2025 [Member]                        
Gross proceeds             $ 2,000,000.0          
Agreed to cancelled, share purchase warrants             70,000          
Share issuance costs             $ 300,000          
Common stock shares sold             2,000,000          
Common stock price per share             $ 1.00          
Exercise price             $ 1.25          
ATM offering [Member]                        
Number of shares issued               6,585        
Proceeds from issuance of common stock               $ 11,720        
Deferred offering costs               $ 94,000        
ATM offering [Member] | On October 2024 [Member]                        
Gross proceeds         $ 26,146              
Common stock shares sold         8,402              
ATM share issuance costs         $ 144,812              
Incentive Equity Plan [Member]                        
Restricted stock granted during period     100,000                  
Fair value of restricted stock granted during period     $ 224,000